
Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China as Competition Intensifies
Dec 31, 2025 01:51 am UTC| Business Health
Novo Nordisk and Eli Lilly are significantly lowering prices of their blockbuster obesity drugs Wegovy and Mounjaro in China, a move aimed at expanding access in one of the worlds fastest-growing weight-loss markets and...

Vanda Pharmaceuticals Wins FDA Approval for New Motion Sickness Drug After Four Decades
Dec 31, 2025 01:47 am UTC| Governance Business Health
Vanda Pharmaceuticals has received approval from the U.S. Food and Drug Administration (FDA) for its drug tradipitant, branded as Nereus, marking the first new FDA-approved treatment for motion-induced vomiting in more...

Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China, Boosting Access to Wegovy and Mounjaro
Dec 30, 2025 10:50 am UTC| Business Health
Novo Nordisk and Eli Lilly are reducing prices for their widely used obesity medications, Wegovy and Mounjaro, in China, a move that could significantly expand patient access in one of the worlds largest pharmaceutical...

Royalty Pharma Stock Rises After Acquiring Full Evrysdi Royalty Rights from PTC Therapeutics
Dec 30, 2025 02:39 am UTC| Business Health
Royalty Pharma Plc (NASDAQ: RPRX) shares rose 1.5% in after-hours trading on Monday after the company announced it had acquired the final portion of PTC Therapeutics remaining royalty interest in Evrysdi, a leading spinal...

Sanofi to Acquire Dynavax in $2.2 Billion Deal to Strengthen Vaccine Portfolio
Dec 25, 2025 02:04 am UTC| Business Health
French pharmaceutical giant Sanofi has announced plans to acquire U.S.-based biotech company Dynavax Technologies in a deal valued at approximately $2.2 billion (1.9 billion). The acquisition, agreed on Wednesday, is aimed...

GLP-1 Weight Loss Pills Set to Reshape Food and Fast-Food Industry in 2025
Dec 25, 2025 01:49 am UTC| Health Business
Packaged food manufacturers and fast-food restaurants are preparing for major shifts in consumer demand as appetite-suppressing GLP-1 weight loss pills are expected to enter the U.S. market in early 2025. Analysts believe...

Sanofi to Acquire Dynavax in $2.2 Billion Deal to Strengthen Vaccines Portfolio
Dec 24, 2025 11:06 am UTC| Business Health
Sanofi has announced an agreement to acquire U.S.-based vaccines company Dynavax Technologies in an all-cash transaction valued at approximately $2.2 billion, marking another strategic move to expand its vaccines business....